EP Patent

EP2300415A2 — Process for controlling the particle size of a 3-(trifluoromethyl)phenyl¨-1-aminopropane derivative

Assigned to Medichem SA · Expires 2011-03-30 · 15y expired

What this patent protects

The invention relates to a process for tightly controlling the particle size of cinacalcet hydrochloride, i.e. a process for preparing large or small crystals of cinacalcet hydrochloride, which yields cinacalcet hydrochloride in a narrow, reproducible and consistent distributio…

USPTO Abstract

The invention relates to a process for tightly controlling the particle size of cinacalcet hydrochloride, i.e. a process for preparing large or small crystals of cinacalcet hydrochloride, which yields cinacalcet hydrochloride in a narrow, reproducible and consistent distribution of particles, which hence does not require to reprocess, rework or destroy material of undesired size, which is efficient and cost-effective, and which is suitable for industrial implementation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2300415A2
Jurisdiction
EP
Classification
Expires
2011-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Medichem SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.